Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | - |
Domain |
PF12796 Ankyrin repeats (3 copies) |
Function |
Recruits CKI-epsilon to the beta-catenin degradation complex that consists of AXN1 or AXN2 and GSK3-beta and allows efficient phosphorylation of beta-catenin, thereby inhibiting beta-catenin/Tcf signals. |
Biological Process |
GO:0001736 establishment of planar polarity GO:0001738 morphogenesis of a polarized epithelium GO:0007164 establishment of tissue polarity GO:0007254 JNK cascade GO:0016055 Wnt signaling pathway GO:0030111 regulation of Wnt signaling pathway GO:0030177 positive regulation of Wnt signaling pathway GO:0030178 negative regulation of Wnt signaling pathway GO:0031098 stress-activated protein kinase signaling cascade GO:0032872 regulation of stress-activated MAPK cascade GO:0032874 positive regulation of stress-activated MAPK cascade GO:0035567 non-canonical Wnt signaling pathway GO:0043410 positive regulation of MAPK cascade GO:0046328 regulation of JNK cascade GO:0046330 positive regulation of JNK cascade GO:0051403 stress-activated MAPK cascade GO:0060070 canonical Wnt signaling pathway GO:0060071 Wnt signaling pathway, planar cell polarity pathway GO:0060828 regulation of canonical Wnt signaling pathway GO:0070302 regulation of stress-activated protein kinase signaling cascade GO:0070304 positive regulation of stress-activated protein kinase signaling cascade GO:0090090 negative regulation of canonical Wnt signaling pathway GO:0090175 regulation of establishment of planar polarity GO:0198738 cell-cell signaling by wnt GO:1905330 regulation of morphogenesis of an epithelium GO:2000027 regulation of organ morphogenesis GO:2000050 regulation of non-canonical Wnt signaling pathway GO:2000052 positive regulation of non-canonical Wnt signaling pathway GO:2000095 regulation of Wnt signaling pathway, planar cell polarity pathway GO:2000096 positive regulation of Wnt signaling pathway, planar cell polarity pathway |
Molecular Function | - |
Cellular Component | - |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between ANKRD6 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of ANKRD6 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of ANKRD6 in various data sets.
|
Points in the above scatter plot represent the mutation difference of ANKRD6 in various data sets.
|
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of ANKRD6. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of ANKRD6. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by ANKRD6. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of ANKRD6. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of ANKRD6 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | ANKRD6 |
Name | ankyrin repeat domain 6 |
Aliases | KIAA0957; diversin; Ankyrin repeat domain-containing protein 6 |
Chromosomal Location | 6q15 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between ANKRD6 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |